{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:23:42Z","timestamp":1792679022536,"version":"4.5.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T00:00:00Z","timestamp":1365033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003264","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T22:18:44Z","timestamp":1365113924000},"page":"e1003264","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":295,"title":["Relative Contribution of Th1 and Th17 Cells in Adaptive Immunity to Bordetella pertussis: Towards the Rational Design of an Improved Acellular Pertussis Vaccine"],"prefix":"10.1371","volume":"9","author":[{"given":"P\u00e1draig J.","family":"Ross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline E.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aideen C.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Misiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed C.","family":"Lavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingston H. G.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group","volume":"334","author":"D Greco","year":"1996","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine","volume":"334","author":"L Gustafsson","year":"1996","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0264-410X(97)00100-X","article-title":"A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal","volume":"15","author":"F Simondon","year":"1997","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1086\/655826","article-title":"The present and future control of pertussis","volume":"51","author":"JD Cherry","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"RE Black","year":"2010","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJMoa1200850","article-title":"Waning protection after fifth dose of acellular pertussis vaccine in children","volume":"367","author":"NP Klein","year":"2012","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"J Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","article-title":"Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children","volume":"93","author":"M Ryan","year":"1998","journal-title":"Immunology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1128\/IAI.65.6.2168-2174.1997","article-title":"Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines","volume":"65","author":"CM Ausiello","year":"1997","journal-title":"Infect Immun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1084\/jem.186.11.1843","article-title":"Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes","volume":"186","author":"BP Mahon","year":"1997","journal-title":"J Exp Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1128\/IAI.65.12.4904-4908.1997","article-title":"Role of gamma interferon in natural clearance of Bordetella pertussis infection","volume":"65","author":"J Barbic","year":"1997","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis","volume":"66","author":"KH Mills","year":"1998","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/IAI.61.8.3190-3198.1993","article-title":"Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity","volume":"61","author":"K Redhead","year":"1993","journal-title":"Infect Immun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1086\/315527","article-title":"Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children","volume":"181","author":"BP Mahon","year":"2000","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.4049\/jimmunol.177.11.7980","article-title":"TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells","volume":"177","author":"SC Higgins","year":"2006","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.4049\/jimmunol.1000105","article-title":"Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis","volume":"185","author":"A Dunne","year":"2010","journal-title":"J Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e8734","DOI":"10.1371\/journal.pone.0008734","article-title":"Bordetella pertussis commits human dendritic cells to promote a Th1\/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways","volume":"5","author":"G Fedele","year":"2010","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e7079","DOI":"10.1371\/journal.pone.0007079","article-title":"Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice","volume":"4","author":"C Andreasen","year":"2009","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2009.01.004","article-title":"Mechanism of action of clinically approved adjuvants","volume":"21","author":"BN Lambrecht","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"SC Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4049\/jimmunol.181.1.17","article-title":"Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3","volume":"181","author":"H Li","year":"2008","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/eji.200838549","article-title":"The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity","volume":"38","author":"L Franchi","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20060285","article-title":"A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis","volume":"203","author":"C Sutton","year":"2006","journal-title":"J Exp Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","article-title":"Critical regulation of early Th17 cell differentiation by interleukin-1 signaling","volume":"30","author":"Y Chung","year":"2009","journal-title":"Immunity"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.4049\/jimmunol.1003597","article-title":"Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity","volume":"186","author":"SJ Lalor","year":"2011","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"P Ye","year":"2001","journal-title":"J Exp Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"KH Mills","year":"1993","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2567.1996.497560.x","article-title":"Th1\/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0","volume":"87","author":"A Barnard","year":"1996","journal-title":"Immunology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0264-410X(98)00235-7","article-title":"An aerosol challenge model of Bordetella pertussis infection as a potential bioassay for acellular pertussis vaccines","volume":"17","author":"DK Xing","year":"1999","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0140-6736(79)91447-8","article-title":"Evidence of whooping-cough-vaccine efficacy from the 1978 whooping-cough epidemic in Hertfordshire","volume":"2","author":"MA Church","year":"1979","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/bmj.285.6338.357","article-title":"Efficacy of pertussis vaccination in England. Report from the PHLS Epidemiological Research Laboratory and 21 Area Health Authorities","volume":"285","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines","volume":"350","author":"P Olin","year":"1997","journal-title":"Lancet"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies","volume":"18","author":"S Mattoo","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"CE Sutton","year":"2009","journal-title":"Immunity"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"H Hemmi","year":"2000","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0165-2478(99)00070-X","article-title":"Interferon-gamma mediated immune effector mechanisms against Bordetella pertussis","volume":"68","author":"BP Mahon","year":"1999","journal-title":"Immunol Lett"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1086\/593682","article-title":"Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells","volume":"175","author":"M Ryan","year":"1997","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.170.3.1504","article-title":"Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses","volume":"170","author":"F Mascart","year":"2003","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1086\/515628","article-title":"Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens","volume":"178","author":"CM Ausiello","year":"1998","journal-title":"J Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1128\/IAI.59.10.3768-3773.1991","article-title":"Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis","volume":"59","author":"S Peppoloni","year":"1991","journal-title":"Infect Immun"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/IAI.00836-07","article-title":"Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses","volume":"76","author":"NK Fennelly","year":"2008","journal-title":"Infect Immun"},{"key":"ref42","first-page":"193","article-title":"Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens","volume":"121","author":"EJ Ryan","year":"2000","journal-title":"ClinExpImmunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.vaccine.2010.01.010","article-title":"Th2-polarisation of cellular immune memory to neonatal pertussis vaccination","volume":"28","author":"OJ White","year":"2010","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1128\/IAI.64.10.4078-4084.1996","article-title":"Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine","volume":"64","author":"F Zepp","year":"1996","journal-title":"Infect Immun"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8130","DOI":"10.1128\/IAI.73.12.8130-8135.2005","article-title":"Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children","volume":"73","author":"J Rowe","year":"2005","journal-title":"Infect Immun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1128\/IAI.67.8.4064-4071.1999","article-title":"Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines","volume":"67","author":"CM Ausiello","year":"1999","journal-title":"Infect Immun"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.4049\/jimmunol.181.7.4965","article-title":"IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa","volume":"181","author":"GP Priebe","year":"2008","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e1000703","DOI":"10.1371\/journal.ppat.1000703","article-title":"Th1\u2013Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice","volume":"5","author":"L Lin","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1053\/j.gastro.2009.02.077","article-title":"Interleukin-17 is a critical mediator of vaccine-induced reduction of Helicobacter infection in the mouse model","volume":"136","author":"D Velin","year":"2009","journal-title":"Gastroenterology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.clim.2012.06.007","article-title":"Osteoarthritis-associated basic calcium phosphate crystals induce pro-inflammatory cytokines and damage-associated molecules via activation of Syk and PI3 kinase","volume":"144","author":"CC Cunningham","year":"2012","journal-title":"Clin Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"SA Khader","year":"2007","journal-title":"Nat Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.4049\/jimmunol.0900164","article-title":"Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity","volume":"183","author":"AS McKee","year":"2009","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.1201946","article-title":"Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion","volume":"189","author":"C Peral de Castro","year":"2012","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/eji.201242569","article-title":"IL-17-producing gammadelta T cells and innate lymphoid cells","volume":"42","author":"CE Sutton","year":"2012","journal-title":"Eur J Immunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1128\/IAI.00590-10","article-title":"Interleukin-1 receptor signaling is required to overcome the effects of pertussis toxin and for efficient infection- or vaccination-induced immunity against Bordetella pertussis","volume":"79","author":"X Zhang","year":"2011","journal-title":"Infect Immun"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1128\/IAI.01150-08","article-title":"Role of neutrophils in response to Bordetella pertussis infection in mice","volume":"77","author":"C Andreasen","year":"2009","journal-title":"Infect Immun"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1128\/IAI.67.11.6109-6118.1999","article-title":"Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection","volume":"67","author":"ET Harvill","year":"1999","journal-title":"Infect Immun"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/eji.200838535","article-title":"Induction, function and regulation of IL-17-producing T cells","volume":"38","author":"KH Mills","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/INF.0b013e31816591f7","article-title":"Safety of a fifth dose of diphtheria and tetanus toxoid and acellular pertussis vaccine in children experiencing extensive, local reactions to the fourth dose","volume":"27","author":"MB Rennels","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"W Hueber","year":"2010","journal-title":"Sci Transl Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1016\/j.vaccine.2004.09.041","article-title":"A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1\/Th2 immune response in diphtheria-tetanus-pertussis vaccine","volume":"23","author":"T Sugai","year":"2005","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"crossref","DOI":"10.4161\/hv.22755","article-title":"A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis","volume":"9","author":"C Asokanathan","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1084\/jem.20011288","article-title":"Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis","volume":"195","author":"P McGuirk","year":"2002","journal-title":"J Exp Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.171.6.3119","article-title":"Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology","volume":"171","author":"SC Higgins","year":"2003","journal-title":"J Immunol"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T23:00:06Z","timestamp":1595631606000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003264"}},"subtitle":[],"editor":[{"given":"Eric T.","family":"Harvill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,4]]},"references-count":64,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003264","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,4]]}}}